Research & development > Clinical diagnostics

6 min Strep A test suitable for remote settings

10 September, 2020

Rapid, molecular point-of-care tests can be used in remote settings to accurately detect the presence of Strep A bacterium in just six minutes.


20 min assay for COVID-19 developed

20 August, 2020

The rapid molecular test, called N1-STOP-LAMP, involves using a small portable machine that can detect SARS-CoV-2 from just one nasal swab.


Non-fasting blood test can screen youth for prediabetes

12 August, 2020

The HbA1c test measures the degree to which sugar molecules have linked irreversibly to molecules in red blood cells in the previous few months.


Tau protein could be key to an Alzheimer's blood test

03 August, 2020 by Lauren Davis

Blood tests based on the tau protein phospho-tau217 (p-tau217) may be able to detect changes in the brain 20 years before dementia symptoms occur.


Radiation sickness detected in a drop of blood

28 July, 2020

The new test uses a single drop of blood — collected from a simple finger prick — and results are ready in a few hours.


New liquid biopsy method detects early kidney cancer

29 June, 2020

The method has been found to detect kidney cancers with high accuracy, including small, localised tumours for which no early detection method currently exists.


New test improves early detection of prostate cancer

17 June, 2020

A groundbreaking new test can improve the early detection of prostate cancer compared with the existing prostate-specific antigen (PSA) blood test.


Saliva tests for COVID-19 could replace nasal swabs

04 June, 2020

Saliva can be used to diagnose the presence and transmission of COVID-19, and to monitor immunity to SARS-Cov-2.


Biomarker signature found for tuberculosis infection

21 May, 2020

The biomarker discovery could be used as the basis for a highly effective and simple diagnostic blood test to help detect prevalent cases of TB in the community.


Diagnostic test tracks the spread of infectious diseases

14 May, 2020

The new diagnostic approach has the potential to enhance infectious diseases surveillance, and so is now being adapted to track immunity to COVID-19.


Fighting the COVID-19 fire with molecular diagnostics innovations

04 May, 2020 by Dr Luyun Jiang, Technology Analyst

Unlike in the influenza pandemic in 1918, today we are better equipped to identify the elusive bug responsible for COVID-19.


Biomarkers for urological cancers found in urine

22 April, 2020

Researchers have developed a new method to enable more timely diagnosis and treatment of urological cancers, ie, prostate, bladder and kidney cancers.


AI blood test can detect over 50 types of cancer

15 April, 2020

A new blood test can accurately detect more than 50 types of cancer and identify in which tissue the cancer originated, often before there are any clinical signs or symptoms.


POC infection diagnosis combats antibiotic resistance

11 March, 2020

A new infection test, made up of sheets of paper patterned by lasers, will enable diagnosis at the point of care — helping doctors give patients the right treatment, and quickly.


Gold nanoparticles used to detect cancer

04 March, 2020

The nanotechnology developed by University of Queensland scientists can detect and monitor extracellular vesicles (EVs) in the bloodstream.


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd